Skip to main content
. 2017 May 3;96(5):1143–1150. doi: 10.4269/ajtmh.16-0373

Table 1.

IC50 of Leishmania isolates and Leishmania guyanensis reference strain according to the medium used and the drug tested

Species Medium Isolate number Promastigote IC50 Clinical outcome§
Amphotericin B Azithromycin Fluconazole Meglumine antimoniate Miltefosine Paromomycin Pentamidine
μg/mL 95% CI μg/mL 95% CI μg/mL 95% CI μg/mL 95% CI μg/mL 95% CI μg/mL 95% CI μg/mL 95% CI
L. guyanensis R 1 4.16 3.50–4.94 > 3,000 3,759 3,252–4,345 9,510 8,768–10,316 3.91 3.25–4.34 < 156.25 0.0013 0.012–0.014 Sensitive presumed
2 11.51 11.17–11.87 > 3,000 5,000–10,000 7,500–15,000 3.9–7.8 < 156.25 0.00078–0.0015 Sensitive
3 4.19 3.52–4.98 192.4 175.9–210.4 3,607 495.2–26,267 5,222 3,666–7,438 < 3.9 < 156.25 0.0011 0.0009–0.001
4 1.87 1.63–2.15 3,057 2,711–3,447 < 3.9 1,211 982.7–1,492 Sensitive
5 1.56–3.12 2,781 2,103–3,676 < 3.9 > 5,000 Sensitive presumed
6 1.58 1.43–1.74 3,353 3,065–3,669 < 3.9 701.8 542.7–907.4
7 5.38 4.70–6.16 3,034 2,860–3,218 < 3.9 1,154 928.8–1,434 0.0065 Sensitive
8 1.89 1.61–2.21 2,562 1,009–6,504 < 3.9 2,314 826.1–6,484 > 0.01 Resistant
9 2.57 2.39–2.77 2,802 2,458–3,193 < 3.9 953.4 365.1–2,489 0.004 0.004–0.005 Sensitive
10 0.78–1.56 < 937.5 5.27 4.69–5.92 < 156.25 0.0025 0.002–0.003 Sensitive
11 9.81 8.86–10.85 15,000–30,000 10.53 7.97–13.90 96.27 53.84–172.2 0.0056 0.005–0.006 Sensitive presumed
12 6.25–12.5 15,000–30,000 10.63 9.10–12.42 359.7 338.5–382.2 0.006 0.003–0.01
13 1.56–3.12 1,597 1,494–1,708 269.7 237.1–306.7 0.0094 0.003–0.02 Resistant
14 1.03 0.85–1.23 < 937.5 < 3.9 56.47 39.93–79.86 0.0059 0.005–0.006 Sensitive
15 3.76 3.12–4.53 1,875–3,750 6.64 5.33–8.26 98.12 89.52–107.5 0.0057 0.005–0.006 Sensitive
Ref* 1.4 1.31–1.492 < 93.75 3,117 3,016–3,222 10,705 9,830–11,657 3.9–7.8 110 75.5–160.3 0.002119 0.0017–0.0025
Isolates interval values in R medium 1.03–12.5 192.4–> 3,000 3,607–10,000 < 937.5–30,000 < 3.9–10.63 < 156.25–> 5,000 0.001–> 0.01
L. guyanensis S 16 6.25–12.5 15,000–30,000 > 125 48.12 14.82–156.3 0.0041 0.003–0.004
17 23.89 0.3079–1,854 > 30,000 10.6 9.17–12.26 < 156.25 0.00312–0.00625 Sensitive presumed
18 6.25–12.5 13,339 10,841–16,412 7.6 6.89–8.39 < 156.25 0.003 0.002–0.003 Sensitive
19 > 25 > 30,000 > 125 267.3 241.9–295.2 > 0.01 Resistant
20 < 3.9 < 156.25 0.00312–0.00625 Sensitive presumed
21 3.12–6.25 9.95 8.17–12.13 < 156.25 0.0025 0.0022–0.0027 Resistant
22 3.1 < 937.5 6.66 5.92–7.50 < 156.25 0.0033 0.002–0.005
23 3.12–6.25 > 30,000 7.8–15.6 < 156.25 0.0026 0.001–0.004 Sensitive
24 3.12–6.25 18,699 4,757–73,501 11.7 10.81–12.66 < 156.25 0.0036 0.0033–0.0039 Intermediate
25 6.25–12.5 3.09 2.57–3.72 98.52 34.45–281.7 0.0015 0.0013–0.0019 Intermediate
26 3.92 < 937.5 1.55 0.17–13.96 < 156.25 0.0033 0.002–0.004
27 4.93 4.82–5.04 102.3 88.52–118.2 3,145 2,995–3,303 18,642 8,707–39,913 < 3.9 738.9 425.7–1,283 0.00312–0.00625
Ref 2.08 0.002–2,044 < 93.75 < 312.5 < 937.5 8.85 4.9–15.9 186.8 134.6–259.2 0.002329 0.00084–0.0064
Isolates interval values in S medium 3.1–> 25 102.3 3,145 < 937.5–> 30,000 < 3.9–> 125 48.12–738.9 0.0015–> 0.01
L. guyanensis R-BH 28 6.25–12.5 187.5–375 2,500–5,000 13,130 12,902–13,362 3.52 3.24–3.82 159.8 134.5–189.9 0.00312–0.00625 Sensitive presumed
29 4.41 4.11–4.73 35.15 17.68–69.89 2,993 2,951–3,035 7,349 4,966–10,875 < 3.9 358.1 275.5–465.4 0.0015–0.00312
30 13.31 12.71–13.94 83.72 74.91–93.58 3,327 3,244–3,411 1.61 0.52–5.01 714.3 611.7–834.2 0.0035 0.003–0.004 Sensitive presumed
31 > 25 177.7 139.3–226.5 4,638 3,505–6,138 > 30,000 < 3.9 4,461 303.6–65,551 0.0028 0.002–0.003
32 3.29 3.21–3.37 < 93.75 2,011 1,893–2,137 4,744 3,343–6,730 < 3.9 0.0015–0.00312
33 7.83 7.38–8.31 < 93.75 2,500–5,000 Intermediate
Ref 2.39 2.27–2.54 < 93.75 2,992 2,773–3,228 10,635 9,424–12,001 6.2 5.9–6.52 77.89 46.15–131.5 0.002537 0.0023–0.0027
Isolates interval values in R–BH medium 3.29–> 25 < 93.75–375 2,011–5,000 4,744–> 30,000 1.61–3.52 159.8–4,461 0.001–0.006
Leishmania braziliensis R–BH 34 1.27 1.08–1.48 83.31 59.73–116.2 830.7 687.6–1,004 3 1.31–6.85 0.0016 0.001–0.002
L. braziliensis R 35 < 0.78 < 3.9 < 156.25 0.00625–0.0125
Leishmania amazonensis R–BH 36 8.35 7.77–8.98 < 93.75 3,105 2,983–3,232 9,822 9,384–10,282 1.95 0.45–8.29 129.6 122.1–137.5 0.00312–0.00625
Total isolates interval values < 0.78–> 25 < 93.75–> 3,000 830.7–10,000 4,744–> 30,000 < 3.9–> 125 < 156.25–> 5,000 0.001–> 0.01

IC50 = 50% inhibitory concentration; R = RPMI 1640 medium; R-BH = RPMI 1640 medium + L-Biopterin and Hemin Chloride; S = Schneider medium (+ L-Biopterin and Hemin Chloride).

*

Ref = Leishmania guyanensis reference strain.

Isolates interval values for each medium according to the drug tested.

Isolates interval values for all medium included, according to the drug tested.

§

Sensitive, cured after one course of pentacarinat; sensitive presumed, presumed cured after one course of pentacarinat (did not consult again); intermediate, cured after two courses of pentacarinat; resistant, cured after three or more courses of pentacarinat.